STAT6
bibliography: 'morinlab.bib' csl: 'NLM.csl' link-citations: true nocite: | @yildizActivatingSTAT6Mutations2015, @ritzRecurrentMutationsSTAT62009, @morinGeneticLandscapesRelapsed2016,
[[TOC]]
The STAT6 gene, which encodes a transcription factor involved in the JAK-STAT signaling pathway, plays a significant role in the pathogenesis of various lymphomas, including diffuse large B-cell lymphoma (DLBCL). Below is a summary of the common mutations in the STAT6 gene identified in DLBCL. Mutations in the DNA binding domain of STAT6 are common in PMBCL and more rare in DLBCL.
Driver mutations affecting this gene in DLBCL/FL have been experimentally demonstrated to cause a gain of function (GOF).[@mentzPARP14NovelTarget2022]
include:tables/table1_STAT6.md
Recurrent mutations at the D419 amino acid residue are a common feature in DLBCL, specifically affecting the germinal center B (GCB) cell subtype. These mutations lead to the activation of the JAK/STAT signaling pathway, contributing to lymphomagenesis [@morinGeneticLandscapesRelapsed2016].
| Chromosome | Coordinate (hg19) | ref>alt | HGVSp |
|---|---|---|---|
| chr12 | 57496671 | C>G | G416R |
| chr12 | 57496666 | G>T | N417K |
| chr12 | 57496662 | C>T | D419N |
| chr12 | 57496662 | C>G | D419H |
| chr12 | 57496662 | C>A | D419Y |
| chr12 | 57496661 | T>G | D419A |
| chr12 | 57496661 | T>C | D419G |
| chr12 | 57496661 | T>A | D419V |
| chr12 | 57496658 | T>G | N420T |
| chr12 | 57496658 | T>C | N420S |
| chr12 | 57496656 | T>C | N421D |
| chr12 | 57496654 | A>C | N421K |
include:tables/browser_STAT6.md
Disclaimer
The content in these pages has been populated, in part, by an automated process. Although we have scrutinized every page to ensure accuracy, errors will inevitably exist. If you find an error please report it as an issue and we will address it.
In particular, let us know if you feel that an important citation is missing or if a paper has been cited incorrectly.
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
Adapt — remix, transform, and build upon the material for any purpose, even commercially. The licensor cannot revoke these freedoms as long as you follow the license terms.